MedImmune to Share Manufacturing Space With Merck & Co., Inc.

MedImmune says it will share its manufacturing space in Frederick with pharmaceutical giant Merck & Co. MedImmune said Wednesday the companies have reached a 15-year deal allowing Merck to use its 385,000-square-foot plant for bulk product manufacturing. MedImmune says it’s also looking at Merck’s facilities for possible production of microbial-based compounds MedImmune is developing. MedImmune says it’s not unusual in the biopharmaceutical industry for companies to share manufacturing capacity.